JP2023524692A5 - - Google Patents
Info
- Publication number
- JP2023524692A5 JP2023524692A5 JP2022566135A JP2022566135A JP2023524692A5 JP 2023524692 A5 JP2023524692 A5 JP 2023524692A5 JP 2022566135 A JP2022566135 A JP 2022566135A JP 2022566135 A JP2022566135 A JP 2022566135A JP 2023524692 A5 JP2023524692 A5 JP 2023524692A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- process according
- solvent
- reaction mixture
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025104881A JP2025128388A (ja) | 2020-04-30 | 2025-06-20 | キナーゼ阻害剤を調製するためのプロセス |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063017739P | 2020-04-30 | 2020-04-30 | |
| US63/017,739 | 2020-04-30 | ||
| PCT/US2021/030035 WO2021222673A1 (en) | 2020-04-30 | 2021-04-30 | Processes for the preparation of a kinase inhibitor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025104881A Division JP2025128388A (ja) | 2020-04-30 | 2025-06-20 | キナーゼ阻害剤を調製するためのプロセス |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023524692A JP2023524692A (ja) | 2023-06-13 |
| JP2023524692A5 true JP2023524692A5 (cg-RX-API-DMAC7.html) | 2024-04-30 |
| JP7728795B2 JP7728795B2 (ja) | 2025-08-25 |
Family
ID=76076455
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022566135A Active JP7728795B2 (ja) | 2020-04-30 | 2021-04-30 | キナーゼ阻害剤を調製するためのプロセス |
| JP2025104881A Pending JP2025128388A (ja) | 2020-04-30 | 2025-06-20 | キナーゼ阻害剤を調製するためのプロセス |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025104881A Pending JP2025128388A (ja) | 2020-04-30 | 2025-06-20 | キナーゼ阻害剤を調製するためのプロセス |
Country Status (27)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20251184T1 (hr) * | 2018-01-26 | 2025-12-05 | Exelixis, Inc. | Spojevi za liječenje poremećaja ovisnih o kinazi |
| AR127561A1 (es) * | 2021-11-03 | 2024-02-07 | Exelixis Inc | Compuestos para el tratamiento de trastornos dependientes de cinasas |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1154105A (zh) | 1994-06-08 | 1997-07-09 | H·隆德贝克有限公司 | 4-芳基-1-(二氢化茚甲基、二氢苯并呋喃甲基或二氢苯并噻吩甲基)哌啶、-四氢吡啶或哌嗪类化合物 |
| ZA954689B (en) | 1994-06-08 | 1996-01-29 | Lundbeck & Co As H | 4-Aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) piperidines tetrahydropyridines or piperazines |
| SMP200900002B (it) | 2006-06-12 | 2010-01-19 | Novartis Ag | Sali di n-idrossi-3-[4-[[[2-(2-metil-1h-indol-3-il)etil]ammino]metil]fenil]-2e-2-propenammide |
| CN101466672B (zh) | 2006-06-12 | 2012-05-16 | 诺瓦提斯公司 | N-羟基-3-[4-[[[2-(2-甲基-1h-吲哚-3-基)乙基]氨基]甲基]苯基]-2e-2-丙烯酰胺的盐 |
| CA2743416A1 (en) * | 2008-11-13 | 2010-05-20 | Exelixis Inc. | Methods of preparing quinoline derivatives |
| TW201920110A (zh) * | 2009-01-16 | 2019-06-01 | 美商艾克塞里克斯公司 | 包含n-(4-{[6,7-雙(甲氧基)喹啉-4-基]氧基}苯基)-n'-(4-氟苯基)環丙烷-1,1-二甲醯胺之蘋果酸鹽之醫藥組合物及其用途 |
| WO2012009722A1 (en) * | 2010-07-16 | 2012-01-19 | Exelixis, Inc. | C-met modulator pharmaceutical compositions |
| PL2768796T3 (pl) | 2011-10-20 | 2020-05-18 | Exelixis, Inc. | Sposób wytwarzania pochodnych chinoliny |
| EA033834B1 (ru) | 2014-07-31 | 2019-11-29 | Exelixis Inc | Способ получения кабозантиниба, меченного фтором-18, и его аналогов |
| AU2019212800B2 (en) | 2018-01-26 | 2024-05-23 | Exelixis, Inc. | Compounds for the treatment of kinase-dependent disorders |
| SG11202006945PA (en) | 2018-01-26 | 2020-08-28 | Exelixis Inc | Compounds for the treatment of kinase-dependent disorders |
| HRP20251184T1 (hr) * | 2018-01-26 | 2025-12-05 | Exelixis, Inc. | Spojevi za liječenje poremećaja ovisnih o kinazi |
| PL3894012T4 (pl) * | 2018-12-13 | 2026-01-05 | Exelixis, Inc. | Postacie krystaliczne i postacie soli inhibitora kinazy |
| CN109761899B (zh) * | 2019-02-14 | 2022-11-15 | 广州六顺生物科技股份有限公司 | 喹啉衍生物、其药学上可接受的盐或其溶剂合物、其应用、药物及药物组合物 |
-
2021
- 2021-04-30 FI FIEP21727657.5T patent/FI4143169T3/fi active
- 2021-04-30 DK DK21727657.5T patent/DK4143169T3/da active
- 2021-04-30 LT LTEPPCT/US2021/030035T patent/LT4143169T/lt unknown
- 2021-04-30 MA MA59466A patent/MA59466B1/fr unknown
- 2021-04-30 TW TW110115786A patent/TWI887405B/zh active
- 2021-04-30 MX MX2022013528A patent/MX2022013528A/es unknown
- 2021-04-30 SI SI202130435T patent/SI4143169T1/sl unknown
- 2021-04-30 JP JP2022566135A patent/JP7728795B2/ja active Active
- 2021-04-30 US US17/922,208 patent/US12497367B2/en active Active
- 2021-04-30 CA CA3176042A patent/CA3176042A1/en active Pending
- 2021-04-30 KR KR1020227037607A patent/KR20230005190A/ko active Pending
- 2021-04-30 AU AU2021263474A patent/AU2021263474A1/en active Pending
- 2021-04-30 PT PT217276575T patent/PT4143169T/pt unknown
- 2021-04-30 PH PH1/2022/552821A patent/PH12022552821A1/en unknown
- 2021-04-30 CN CN202180031136.7A patent/CN115461328B/zh active Active
- 2021-04-30 CR CR20220551A patent/CR20220551A/es unknown
- 2021-04-30 WO PCT/US2021/030035 patent/WO2021222673A1/en not_active Ceased
- 2021-04-30 EP EP21727657.5A patent/EP4143169B1/en active Active
- 2021-04-30 RS RS20260593A patent/RS68116B1/sr unknown
- 2021-04-30 BR BR112022021712A patent/BR112022021712A2/pt unknown
- 2021-04-30 GE GEAP202516101A patent/GEP20267875B/en unknown
- 2021-04-30 HR HRP20260608TT patent/HRP20260608T1/hr unknown
- 2021-04-30 PE PE2022002513A patent/PE20230110A1/es unknown
- 2021-04-30 SM SM20260219T patent/SMT202600219T1/it unknown
- 2021-04-30 CN CN202511511945.4A patent/CN121591655A/zh active Pending
-
2022
- 2022-10-26 IL IL297684A patent/IL297684B2/en unknown
- 2022-10-26 CO CONC2022/0015205A patent/CO2022015205A2/es unknown
- 2022-10-28 CL CL2022003008A patent/CL2022003008A1/es unknown
-
2025
- 2025-06-20 JP JP2025104881A patent/JP2025128388A/ja active Pending
- 2025-10-21 IL IL324105A patent/IL324105A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6307087B2 (ja) | ベンズアミド化合物の合成に有用な化合物 | |
| JP6811717B2 (ja) | トピロキソスタット及びその中間体の調製のための方法 | |
| TWI697494B (zh) | 科帕利普(copanlisib)及其二鹽酸鹽之合成 | |
| KR20180038460A (ko) | 세포독성 벤조다이아제핀 유도체의 제조 방법 | |
| JP4390861B2 (ja) | アクリジン誘導体多剤耐性阻害薬の合成 | |
| JP2004517897A (ja) | テモゾロミドおよびアナログの合成 | |
| JP6014912B2 (ja) | ベンダムスチンアルキルエステル、ベンダムスチン、およびそれらの誘導体の製造のためのプロセス | |
| JP2007522213A (ja) | 置換されたトリアゾール化合物の製造方法 | |
| RU2194706C2 (ru) | Способ получения дигидрохлорида 1-[[[5-(4-хлорфенил)-2-фуранил]метилен]амино]-3-[4-(4-метил-1-пиперазинил) бутил]-2,4-имидазолидиндиона | |
| KR100574350B1 (ko) | 2-아미노피리딘 유도체의 제조방법 | |
| JP2024509995A (ja) | リスジプラムを調製するための方法 | |
| JP2023548368A5 (cg-RX-API-DMAC7.html) | ||
| JP4157766B2 (ja) | 置換イミダゾピリジン化合物の製造方法 | |
| JP5453026B2 (ja) | ヒドラジノトリアジン誘導体の製造方法、5−アミノピラゾール誘導体の製造方法、及び、5−アミノピラゾール誘導体 | |
| RU2194705C2 (ru) | Способ получения 1,3-дизамещенных 4-оксоциклических мочевин | |
| CN105294697B (zh) | 2-氨基-5,8-二甲氧基[1,2,4]三唑并[1,5-c]嘧啶的合成方法 | |
| JP7683005B2 (ja) | Pi3k阻害剤としての化合物の製造方法及びその製造のための中間体化合物 | |
| JP2026058357A (ja) | イミダゾピリジノン化合物の製造方法及び中間体 | |
| JPWO2005063678A1 (ja) | フェニル酢酸誘導体の製造方法 | |
| CN118834203A (zh) | 瑞卢戈利中间体的制备方法 | |
| KR101152607B1 (ko) | 6-[4-(2-피페리딘-1-일-에톡시)-페닐]-3-피리딘-4-일-피라졸로[1,5-a]피리미딘의 제조방법 | |
| SK50402005A3 (sk) | Spôsob prípravy zaleplonu | |
| CN119954778A (zh) | 一种来那卡帕韦钠及其系列中间体化合物的合成方法 | |
| CN116804009A (zh) | 用于合成TGF-β抑制剂的中间体及使用该中间体制备TGF-β抑制剂的方法 | |
| JPS6145622B2 (cg-RX-API-DMAC7.html) |